|
|
||||||||
1 Department of Biochemistry, East Carolina University School of Medicine, Greenville, North Carolina 27858; 2 Department of Biochemistry and Molecular Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73190; and 3 Department of Physiology and Biophysics, The University of Iowa, Iowa City, Iowa 52242
| |
ABSTRACT |
|---|
|
|
|---|
Because GLUT-4 expression is decreased whereas GLUT-1 expression is increased in denervated skeletal muscle, we examined the effects of denervation on GLUT-4 and GLUT-1 gene transcription. The right hindlimb skeletal muscle of male transgenic mice containing sequential truncations (2,400, 1,639, 1,154, and 730 bp) of the human GLUT-4 promoter linked to the chloramphenacol acyl transferase (CAT) gene was denervated, and the contralateral hindlimb was sham operated. RNase protection analysis revealed that after 72 h denervation decreased CAT mRNA and GLUT-4 mRNA levels 64-85%, respectively (P < 0.05), in the gastrocnemius muscles. In contrast, denervation of the right hindlimb of male rats increased GLUT-1 gene transcription and GLUT-1 mRNA levels by 94 and 213%, respectively (P < 0.05). In conclusion, GLUT-4 transcription is decreased but GLUT-1 transcription is increased in denervated skeletal muscle, suggesting that the effects of denervation on GLUT-4 and GLUT-1 expression are, in part, transcriptionally mediated. Furthermore, these data indicate that a DNA sequence regulated by denervation is located within 730 bp of the 5'-flanking promoter region of the human GLUT-4 gene.
gene expression; innervation; insulin resistance
| |
INTRODUCTION |
|---|
|
|
|---|
GLYCEMIC CONTROL appears to be largely dependent on glucose disposal in skeletal muscle, inasmuch as ~75% of the postprandial glucose load is deposited within this tissue (10). GLUT-4 and GLUT-1 are the predominant facilitative glucose transporters within skeletal muscle (27), although they are expressed and regulated differently. GLUT-4 is found in adipose tissue, heart, and skeletal muscle (21, 22, 30), and in response to insulin binding to its receptor a signal cascade is initiated that culminates in the recruitment of GLUT-4 protein from intracellular vesicles to the plasma membrane (9). On the other hand, GLUT-1 is expressed in most tissues (1), is constitutively found on the plasma membrane (14), and is responsible for the majority of basal glucose transport (34).
The expression of GLUT-4 and GLUT-1 proteins in skeletal muscle is altered after 72 h of denervation (2, 7). These latent changes in GLUT-4 protein, therefore, cannot explain the rapid onset of insulin resistance that occurs in skeletal muscle within 3 h of denervation (36). However, the severity of insulin resistance associated with denervation increases with time and reaches a maximum after 72 h (36) and is thought to be related to a reduction in GLUT-4 protein (7). According to Handberg et al. (15), the decrease in GLUT-4 protein is compensated for, in part, by an increase in GLUT-1, to offset the reduction in insulin-stimulated glucose transport.
GLUT-4 and GLUT-1 protein expression in denervated skeletal muscle appears to be dependent on changes in mRNA. Decremental changes in GLUT-4 protein in denervated muscle are paralleled by lower levels of GLUT-4 mRNA, whereas incremental changes in GLUT-1 protein are associated with higher levels of GLUT-1 mRNA (5, 28). However, it is not known whether these changes in GLUT-4 and GLUT-1 mRNA levels after denervation are due to altered rates of transcription. The purpose of this study was to determine whether the changes in GLUT-4 and GLUT-1 protein expression in denervated skeletal muscle are transcriptionally mediated. Results of this study demonstrated that denervation decreased GLUT-4 transcription but increased GLUT-1 transcription in rodent skeletal muscle.
| |
METHODS |
|---|
|
|
|---|
Materials.
Radiolabeled UTP and dATP were obtained from DuPont-New England
Nuclear. DNA polymerase I (Klenow fragment) and restriction enzymes
were purchased from Promega (Madison, WI). RNasin and nonradiolabeled
nucleotides CTP, GTP, ATP, and TTP were obtained from Pharmacia
(Uppsala, Sweden). TRIzol reagent was purchased from GIBCO-BRL
(Gaithersburg, MD). Unless mentioned, all other reagents were of
molecular biology grade and were obtained from Sigma Chemical (St.
Louis, MO), Fischer Scientific (Springfield, NJ), or Pharmacia. The
cDNA probes used in this study were as follows: GLUT-1, a 2.7-kb
EcoR I fragment encoding the 3T3-L1 homolog of the HepG2/brain glucose transporter protein (20);
-galactosidase, a 1.3-kb Sma
I/EcoR V fragment (Clonetech
Laboratories, Palo Alto, CA); and pRibo (18S ribosomal RNA), a 2.0-kb
Hind III fragment.
Mouse experiments.
Transgenic mice were generated as previously described (26) using cDNA
constructs from the plasmid containing 2,400 bp of the GLUT-4
5'-flanking DNA. The cDNA constructs used have identical 3'
ends (+163 bp) but contain sequential deletions (Fig.
1) from the 5' end (
2,400,
1,639,
1,154, and
730 bp). Transgenic mice were
used in the GLUT-4 study, because they provided a powerful tool to
determine the effects of denervation on GLUT-4 transcription as well as
the general location of a DNA sequence that is responsive to this
perturbation. Transgenic mice were identified by Southern analysis of
isolated tail DNA, as previously described (26). Male transgenic mice
(>8 wk) were anesthetized with a ketamine (18 mg/ml)-xylazine (2 mg/ml) mixture (0.05 ml/10 g body wt ip), then the right hindlimb was
denervated via sciatic nerve section (n = 4-7/group). The
contralateral hindlimb was sham operated. Seventy-two hours after
surgery, mice were stunned and killed by cervical dislocation.
Gastrocnemius muscles were harvested and quick frozen to the
temperature of liquid nitrogen for RNA isolation. Transgenic mice were
provided food and water ad libitum. Room temperature (20-22°C)
and lighting (12:12-h light-dark cycle) were controlled.
|
Rat experiments. Eighteen male Sprague-Dawley rats (384 ± 2 g, 14-16 wk old; Harlan Sprague Dawley, Indianapolis, IN) were anesthetized with pentobarbital sodium (4.8 mg/100 g body wt ip), and the sciatic nerve in the right hindlimb was severed. The left hindlimb was sham operated to serve as a control. Seventy-two hours after surgery, rats were stunned and killed by cervical dislocation, and the soleus and gastrocnemius muscles were harvested, pooled, and minced for the isolation of nuclei. Approximately 80 mg of mixed gastrocnemius muscle from each hindlimb were quick frozen to the temperature of liquid nitrogen for RNA isolation. To ensure sufficient tissue for nuclear and RNA isolation, the hindlimb muscles from three rats were pooled to make one sample. Rats were provided food and water ad libitum. Room temperature (20-22°C) and lighting (12:12-h light-dark cycle) were controlled.
|
RNA isolation and Northern analysis.
RNA was isolated from mixed gastrocnemius muscle using TRIzol reagent
according to manufacturer's instructions, as previously described
(35). RNA (20 µg/sample) was size fractionated on a 1.25% agarose-2
M formaldehyde gel and then electrotransferred to a Hybond
N+ membrane. Blots were probed
with random primed
[
-32P]dATP-labeled
cDNA probes (13) for GLUT-1 and 18S ribosomal RNA. Northern blots were
visualized by phosphor imaging and quantitated using Imagequant
software (Molecular Dynamics, Sunnyvale, CA).
Nuclear isolation and transcriptional run-on analysis.
Nuclei were isolated from pooled soleus and gastrocnemius muscles
according to the method of Zahradka et al. (42) with certain modifications (32). Transcriptional run-on analysis was performed using
techniques described by Cornelius et al. (8) with certain modifications
(32). Briefly, radiolabeled RNA transcripts were isolated using TRIzol
reagent, as described above, less the 4 M LiCl wash. RNA pellets were
resuspended in 1.0 ml of Hybrisol I (Oncor, Gaithersburg, MD), heated
for 10 min at 65°C, and then triturated to ensure denaturation of
the RNA. The concentration (cpm/µl) of
32P-labeled RNA was determined by
liquid scintillation spectrometry. Hybridization was done on a Hybond
N+ membrane to which 2 µg of
GLUT-1 and
-galactosidase cDNA and 0.1 µg of genomic DNA were
cross-linked. Genomic DNA and the cDNAs of interest were denatured in
0.1 M NaOH for 30 min at 37°C, neutralized in 10× standard
sodium phosphate EDTA (SSPE; 1× SSPE = 0.15 M NaCl, 0.01 M
NaHPO4, 1.0 mM EDTA, pH 7.4), and
applied to a Hybond N+ membrane by
using a slot-blot apparatus (Mini-fold II, Schleicher and Schuell,
Keene, NH). Each membrane was trimmed and placed in a bag with 1 ml of
sample. All membranes were prehybridized for 3 h in 1.0 ml of Hybrisol
I at 47°C. Hybridization was done for 3 days at 47°C, then
filters were rinsed for 30 min at 50°C in 2× standard saline
citrate (SSC), 30 min at 37°C in 2× SSC containing 10 µg/ml
of RNase A, and 30 min at 55° in 0.1× SSC and 0.1% SDS.
After they were dried, membranes were placed on a phosphor-imager
screen for 3 days. All bands were visualized by phosphor imaging and
quantitated using Imagequant software. All transcripts were
normalized to genomic DNA.
RNase protection assay.
The mouse GLUT-4-chloramphenacol acyl transferase (CAT) plasmid
p469GLUT4.CAT (a gift from Dr. M. Daniel Lane, Johns Hopkins Medical
School, Baltimore, MD) was linearized with
Bsu 36I and then used to generate an
antisense RNA probe. The synthesis of the radioactive
([
-32P]UTP, 800 Ci/mmol) antisense RNA was done using Ambion's T3 MAXscript in vitro
transcription kit (Austin, TX). The RNase protection assay (RPA) was
performed using the streamlined procedure of Ambion's RPA II kit
(Austin, TX). Briefly, 500,000 cpm of labeled probe in 3-15 µl
of elution buffer (0.5 M ammonium acetate, 1 mM EDTA, and 0.2% SDS)
were hybridized to 10-20 µg of total RNA in 20 µl of
hybridization buffer (80% deionized formamide, 100 mM sodium citrate,
pH 6.4, 300 mM sodium acetate, pH 6.4, and 1 mM EDTA). Samples were
incubated overnight at 42-45°C. Nonhybridized RNA was digested
using a 1:100 dilution of RNase A-T1 mix. The protected RNA fragments
for CAT and GLUT-4 are 258 and 176 nucleotides, respectively. A 6%
polyacrylamide gel containing 7 M urea (SequaGel 6, National
Diagnostics, Atlanta, GA) was used to size fractionate the RNA. Results
were visualized by phosphor imaging and quantitated using Imagequant
software.
Statistical analysis. To determine a significant difference between treatment means, a one-tailed paired t-test or a one-tailed Wilcoxon signed rank test was performed with significance set at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
The purpose of the first experiment was to determine whether GLUT-4
gene transcription is decreased in denervated skeletal muscle. RPA
indicated that, after 72 h of denervation, GLUT-4 and CAT mRNA levels
decreased 64-85% in gastrocnemius muscles of mice harboring
2,400,
1,639,
1,154, and
730 bp of the
human GLUT-4 promoter (Fig. 2). This
decrease in GLUT-4 mRNA levels is consistent with previously reported
decrements in GLUT-4 mRNA after denervation (2, 7). The reduction in
mRNA levels of the reporter gene, CAT, indicates that GLUT-4
transcription is decreased in denervated skeletal muscle and could
therefore account for the lower levels of GLUT-4 mRNA (Fig. 2).
Furthermore, these findings suggest that the DNA element(s) in skeletal
muscle regulated by denervation may be within 730 bp of the
5'-flanking promoter region (Fig. 2). To substantiate the effects
of denervation on the expression of the transgene, CAT mRNA-to-GLUT-4
mRNA ratios were compared between control and denervated samples of the
respective constructs. Except for the
1,154-bp construct, where
denervated samples had a lower ratio
(P < 0.05), there were no
differences between control and denervated samples (data not shown),
indicating that the transgene was regulated by denervation like the
endogenous GLUT-4 gene.
|
Previous studies showed that GLUT-1 mRNA and protein levels are altered in a fashion reciprocal to that of GLUT-4 mRNA and protein levels in denervated skeletal muscle (2, 7). In a second experiment, denervation of the right hindlimb skeletal muscles of male rats increased GLUT-1 gene transcription 94% (Fig. 3). Northern analysis indicated that GLUT-1 mRNA increased 213% in denervated mixed gastrocnemius muscles (Fig. 4). Although a 94% increase in transcription of the GLUT-1 gene contributes to the 213% increase in GLUT-1 mRNA levels, these results may suggest posttranscriptonal control (e.g., mRNA stability) of GLUT-1 expression in denervated skeletal muscle.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The expression of GLUT-4 and GLUT-1 glucose transporters in rodent skeletal muscle is a complex and dynamic process dependent on exercise, age, and the hormonal/nutritional state of the animal. In addition, previous studies have demonstrated that denervation has many rapid and dramatic effects on GLUT-4 and GLUT-1 protein expression in skeletal muscle (2, 7). In response to exercise (32) and fasting (31), GLUT-4 protein is increased but is decreased in cases of streptozotocin-induced diabetes (31), eccentric exercise (23), and denervation (2, 7, 16, 29). All these perturbations have been shown to result in alterations in GLUT-4 gene transcription similar to changes in GLUT-4 protein, except for denervation, which has not been studied. Results of these experiments demonstrated that denervation decreased GLUT-4 transcription and increased GLUT-1 transcription in rodent skeletal muscle.
The expression of a gene product is a multistep process that includes transcription, nascent RNA processing, mRNA stability, mRNA translation, and protein processing, transport, and degradation. As described by Williams and Neufer (40), certain kinetic principles govern the flow of information from DNA to RNA to protein. Under steady-state conditions the abundance of a protein is determined by the rate of synthesis (translation) and the rate of degradation. The rate at which a protein is synthesized is determined, in part, by the abundance of the respective mRNA. The amount of mRNA is similarly dependent on the rate at which it is produced (transcription) and degraded (stability). Together, these synthetic and degradative processes determine the synthesis of a gene product, with the kinetics of the rate-limiting steps governing the rate of gene expression. Although transcription is often the rate-limiting step in the synthesis of proteins, other steps may be rate limiting, and such steps may change in response to different stimuli. By determining the effects of denervation on GLUT-4 and GLUT-1 gene transcription, a greater understanding of those processes (e.g., transcription, mRNA stability, translational control) that impact expression of these two genes is acquired.
The 65-85% reduction in transcription of the GLUT-4 gene could account for the 64-79% decline in GLUT-4 mRNA levels (Fig. 2). However, it is questionable that a 94% increase in transcription of the GLUT-1 gene (Fig. 3) could account for the entire 213% rise in GLUT-1 mRNA levels (Fig. 4). Previous studies have indicated that the stability of GLUT-4 and GLUT-1 transcripts is regulated differently in L6E9 myotubes and/or 3T3-L1 adipocytes. Treatment of these cells with 8-bromoadenosine 3',5'-cyclic monophosphate decreased transcription of the GLUT-4 gene but did not alter the half-life of the GLUT-4 transcript (19, 38). In contrast, GLUT-1 transcription rates and the GLUT-1 mRNA half-life are increased after treatment with 8-bromoadenosine 3',5'-cyclic monophosphate (19). Previous research has indicated that intracellular concentrations of cAMP are elevated in denervated skeletal muscle (4, 6, 17) and may influence expression of the GLUT-4 and GLUT-1 genes (18, 38).
The data presented here demonstrate that the transcription rates of GLUT-4 and GLUT-1 are altered in denervated skeletal muscle. The transcriptional mechanisms involved with denervation remain unknown; however, evidence suggests that the MyoD family, a group of myogenic transcription factors, may be involved in regulating GLUT-4 and GLUT-1 expression. Myogenin and MyoD are two members of the MyoD family that bind to CANNTG elements of muscle genes (24, 25, 33, 39). Nonmuscle cells are committed to become myoblasts when transfected with the cDNA for myogenin or MyoD (11). It has been reported that mRNA levels of MyoD and myogenin decrease with postnatal development and increase with denervation (3, 12, 41). Electrical stimulation of denervated skeletal muscle represses the increase of MyoD and myogenin transcripts (3, 12). Recently, Vinals et al. (37) demonstrated that MyoD repression of Sp1 protein may explain the reduction of GLUT-1 expression during muscle cell maturation. Although we did not explore potential regulatory elements within the GLUT-1 promoter, results from this study suggest that a DNA element responsive to denervation exists within 730 bp of the 5'-flanking promoter region of the human GLUT-4 gene. Analysis of the human GLUT-4 gene reveals that three binding sites (CANNTG) for myogenin and MyoD exist within 730 bp of the 5' flank. Whether MyoD and myogenin directly regulate GLUT-4 and GLUT-1 in skeletal muscle remains to be determined.
In summary, GLUT-4 transcription is decreased 65-85%, whereas GLUT-1 transcription is increased 94%, in denervated skeletal muscle. We believe that the 64-79% reduction in GLUT-4 mRNA levels is transcriptionally mediated, whereas the 213% increase in GLUT-1 mRNA levels suggests the involvement of posttranscriptional control. Furthermore, a DNA sequence that is regulated by denervation may lie within 730 bp of the 5'-flanking promoter region of the human GLUT-4 gene. We speculate that the reciprocal changes in GLUT-4 and GLUT-1 protein in denervated skeletal muscle involve transcriptional and posttranscriptional control.
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge the expert technical assistance of Qian Zhou, Steven Pohnert, Carol Culbreth, Braden Boone, Donghai Zheng, and Brian Roberts, Gregory Boyd, William Perkins, and Ray Joyner.
| |
FOOTNOTES |
|---|
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-38416.
Address for reprint requests: J. P. Jones, Dept. of Biochemistry, School of Medicine, East Carolina University, Greenville, NC 27858.
Received 28 July 1997; accepted in final form 14 January 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bell, G.,
T. Kayano,
J. Buse,
C. Burant,
J. Takeda,
D. Lin,
H. Fukumoto,
and
S. Seino.
Molecular biology of mammalian glucose transporters.
Diabetes Care
13:
198-208,
1990[Abstract].
2.
Block, N.,
D. Menick,
K. Robinson,
and
M. Buse.
Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle.
J. Clin. Invest.
88:
1546-1552,
1991.
3.
Buonanno, A.,
L. Apone,
M. Morasso,
R. Beers,
H. Brenner,
and
R. Eftimie.
The MyoD family of myogenic factors is regulated by electrical activity: isolation and characterization of a mouse Myf-5 cDNA.
Nucleic Acids Res.
20:
539-544,
1992
4.
Carlsen, R.
The possible role of cyclic AMP in the neurotrophic control of skeletal muscle.
J. Physiol. (Lond.)
247:
343-361,
1975
5.
Castello, A.,
J. Cadefau,
R. Cusso,
X. Testar,
J. Hesketh,
M. Palacin,
and
A. Zorzano.
GLUT4 and GLUT1 glucose transporter expression is differentially regulated by contractile activity in skeletal muscle.
J. Biol. Chem.
268:
14998-15003,
1993
6.
Chahine, K.,
E. Baracchini,
and
D. Goldman.
Coupling muscle electrical activity to gene expression via a cAMP-dependent second messenger system.
J. Biol. Chem.
268:
2893-2898,
1993
7.
Coderre, L.,
M. Monfar,
K. Chen,
S. Heydrick,
T. Kurowski,
N. Ruderman,
and
P. Pilch.
Alteration in the expression of GLUT-1 and GLUT-4 protein and messenger RNA levels in denervated rat muscles.
Endocrinology
131:
1821-1825,
1992
8.
Cornelius, P.,
M. Marlowe,
M. D. Lee,
and
P. H. Pekala.
The growth factor-like effects of tumor necrosis factor-
. Stimulation of glucose transport and induction of glucose immediate early gene expression in 3T3-L1 preadipocytes.
J. Biol. Chem.
265:
20506-20516,
1990
9.
Cushman, S. W.,
and
L. J. Wardzala.
Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane.
J. Biol. Chem.
255:
4758-4762,
1980
10.
Davidson, M. B.
Role of glucose transport and GLUT4 transporter protein in type 2 diabetes mellitus.
J. Clin. Endocrinol. Metab.
77:
25-26,
1993[Medline].
11.
Davis, R.,
H. Weintraub,
and
A. Lasser.
Expression of a single transfected cDNA converts fibroblasts to myoblasts.
Cell
51:
987-1000,
1987[Medline].
12.
Eftimie, R.,
H. Brenner,
and
A. Buonanno.
Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity.
Proc. Natl. Acad. Sci. USA
88:
1349-1353,
1991
13.
Feinberg, A. P.,
and
B. Vogelstein.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
Anal. Biochem.
132:
6-13,
1983[Medline].
14.
Goodyear, L.,
M. Hirshman,
R. Smith,
and
E. Horton.
Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle.
Am. J. Physiol.
261 (Endocrinol. Metab. 24):
E556-E561,
1991
15.
Handberg, A.,
L. Megeney,
K. McCullagh,
L. Kayser,
X. Han,
and
A. Bonen.
Reciprocal GLUT-1 and GLUT-4 expression and glucose transport in denervated muscles.
Am. J. Physiol.
271 (Endocrinol. Metab. 34):
E50-E57,
1996
16.
Henriksen, E.,
K. Rodnick,
C. Mondon,
D. James,
and
J. Holloszy.
Effect of denervation or unweighting on GLUT-4 protein in rat soleus muscle.
J. Appl. Physiol.
70:
2322-2327,
1991
17.
Hopkins, D.,
and
K. Manchester.
Cyclic nucleotides in the denervated rat diaphragm and the effect of cyclic AMP on ornithine and adenosylmethionine decarboxylases.
Biochim. Biophys. Acta
678:
388-394,
1982.
18.
Jones, J. P.,
and
G. L. Dohm.
Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine.
Am. J. Physiol.
273 (Endocrinol. Metab. 36):
E682-E687,
1997
19.
Kaestner, K. H.,
J. R. Flores-Riveros,
J. C. McLenithan,
M. Janicot,
and
M. D. Lane.
Transcriptional repression of the mouse insulin-responsive glucose transporter (GLUT4) gene by cAMP.
Proc. Natl. Acad. Sci. USA
88:
1933-1937,
1991
20.
Kaestner, K. H.,
J. C. McLenithan,
R. Christy,
L. T. Braiteiman,
P. Cornelius,
P. H. Pekala,
and
M. D. Lane.
Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.
Proc. Natl. Acad. Sci. USA
86:
3150-3154,
1989
21.
Kasanicki, M. A.,
and
P. F. Pilch.
Regulation of glucose-transporter function.
Diabetes Care
13:
219-227,
1990[Abstract].
22.
Klip, A.,
and
A. Marette.
Acute and chronic signals controlling glucose transport in skeletal muscle.
J. Cell. Biochem.
48:
51-60,
1992[Medline].
23.
Kristiansen, S.,
J. Jones,
A. Handberg,
G. Dohm,
and
E. Richter.
Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle.
Am. J. Physiol.
272 (Cell Physiol. 41):
C1734-C1738,
1997
24.
Lassar, A.,
J. Buskin,
D. Lockshon,
R. Davis,
S. Apone,
S. Hauschka,
and
H. Weintraub.
MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer.
Cell
58:
823-831,
1989[Medline].
25.
Lin, H.,
K. Yutzey,
and
S. Konieczny.
Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors.
Mol. Cell. Biol.
11:
267-280,
1991
26.
Liu, M.,
A. L. Olson,
W. S. Moye-Rowley,
J. B. Buse,
G. I. Bell,
and
J. E. Pessin.
Expression and regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice.
J. Biol. Chem.
267:
11673-11676,
1992
27.
Marette, A.,
J. Richardson,
T. Ramlal,
T. Balon,
M. Vranic,
J. Pessin,
and
A. Klip.
Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscles.
Am. J. Physiol.
263 (Cell Physiol. 32):
C443-C452,
1992
28.
Megeney, L.,
R. Michel,
C. Boudreau,
P. Fernando,
M. Tan,
M. Prasad,
and
A. Bonen.
Regulation of muscle glucose transport and GLUT-4 by nerve-derived factors and activity-related processes.
Am. J. Physiol.
269 (Regulatory Integrative Comp. Physiol. 38):
R1148-R1153,
1995
29.
Megeney, L.,
P. Neufer,
G. Dohm,
M. Tan,
C. Blewtt,
G. Elder,
and
A. Bonen.
Effects of muscle activity and fiber composition on glucose transport and GLUT-4.
Am. J. Physiol.
264 (Endocrinol. Metab. 27):
E583-E593,
1993
30.
Mueckler, M.
Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes.
Diabetes
39:
6-11,
1990[Abstract].
31.
Neufer, P. D.,
J. O. Carey,
and
G. L. Dohm.
Transcriptional regulation of the gene for glucose transporter GLUT4 in skeletal muscle. Effects of diabetes and fasting.
J. Biol. Chem.
268:
13824-13829,
1993
32.
Neufer, P. D.,
and
G. L. Dohm.
Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle.
Am. J. Physiol.
265 (Cell Physiol. 34):
C1597-C1603,
1993
33.
Piette, J.,
J. Bessereau,
M. Huchet,
and
J. Changeux.
Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor a-subunit gene.
Nature
45:
353-355,
1990.
34.
Ren, J.,
B. Marshall,
E. Gulve,
J. Goa,
D. Johnson,
J. Holloszy,
and
M. Mueckler.
Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle.
J. Biol. Chem.
268:
16113-16115,
1993
35.
Torrance, C.,
J. Devente,
J. Jones,
and
G. Dohm.
Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.
Endocrinology
138:
1204-1214,
1997
36.
Turinsky, J.
Dynamics of insulin resistance in denervated slow and fast muscles in vivo.
Am. J. Physiol.
252 (Regulatory Integrative Comp. Physiol. 21):
R531-R537,
1987
37.
Vinals, F.,
C. Fandos,
T. Santalucia,
J. Ferre,
X. Testar,
M. Palacin,
and
A. Zorzano.
Myogenesis and MyoD down-regulate Spl.
J. Biol. Chem.
272:
2913-12921,
1997.
38.
Vinals, F.,
J. Ferré,
C. Fandos,
T. Santalucia,
X. Testar,
M. Palacin,
and
A. Zorzano.
Cyclic adenosine 3',5'-monophosphate regulates GLUT4 and GLUT1 glucose transporter expression and stimulates transcriptional activity of the GLUT1 promoter in muscle cells.
Endocrinology
138:
2521-2529,
1997
39.
Wentworth, B.,
M. Donoghue,
J. Engert,
E. Berglund,
and
N. Rosenthal.
Paired MyoD-binding sites regulate myosin light chain gene expression.
Proc. Natl. Acad. Sci. USA
88:
1242-1246,
1991
40.
Williams, R. S.,
and
P. D. Neufer.
Regulation of gene expression in skeletal muscle by contractile activity.
In: Textbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. New York: Oxford University Press, 1996, p. 1124-1150.
41.
Witzemann, V.,
and
B. Sakmann.
Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity.
Federation Eur. Biochem. Soc.
282:
259-264,
1991.
42.
Zahradka, P.,
D. E. Larson,
and
B. H. Sells.
RNA polymerase II-directed gene transcription by rat skeletal muscle nuclear extracts.
Exp. Cell Res.
85:
8-20,
1989.
This article has been cited by other articles:
![]() |
E. B. Jensen, D. Zheng, R. A. Russell, R. Bassel-Duby, R. S. Williams, A. L. Olson, and G. L. Dohm Regulation of GLUT4 expression in denervated skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1820 - R1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Koves, P. Li, J. An, T. Akimoto, D. Slentz, O. Ilkayeva, G. L. Dohm, Z. Yan, C. B. Newgard, and D. M. Muoio Peroxisome Proliferator-activated Receptor-{gamma} Co-activator 1{alpha}-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency J. Biol. Chem., September 30, 2005; 280(39): 33588 - 33598. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Holmes, D. B. Lang, M. J. Birnbaum, J. Mu, and G. L. Dohm AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E739 - E743. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Moreno, A. L. Serrano, T. Santalucia, A. Guma, C. Canto, N. J. Brand, M. Palacin, S. Schiaffino, and A. Zorzano Differential Regulation of the Muscle-specific GLUT4 Enhancer in Regenerating and Adult Skeletal Muscle J. Biol. Chem., October 17, 2003; 278(42): 40557 - 40564. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Dohm Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Regulation of skeletal muscle GLUT-4 expression by exercise J Appl Physiol, August 1, 2002; 93(2): 782 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Paulsen, D. S. Rubink, and W. W. Winder AMP-activated protein kinase activation prevents denervation-induced decline in gastrocnemius GLUT-4 J Appl Physiol, November 1, 2001; 91(5): 2102 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zheng, P. S. MacLean, S. C. Pohnert, J. B. Knight, A. L. Olson, W. W. Winder, and G. L. Dohm Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase J Appl Physiol, September 1, 2001; 91(3): 1073 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Suarez, D. Bach, J. Cadefau, M. Palacin, A. Zorzano, and A. Guma A Novel Role of Neuregulin in Skeletal Muscle. NEUREGULIN STIMULATES GLUCOSE UPTAKE, GLUCOSE TRANSPORTER TRANSLOCATION, AND TRANSPORTER EXPRESSION IN MUSCLE CELLS J. Biol. Chem., May 18, 2001; 276(21): 18257 - 18264. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |